Liver as a target for oligonucleotide therapeutics

Article ID	Journal	Published Year	Pages	File Type
6104037	Journal of Hepatology	2013	6 Pages	PDF

Keywords

PCSK9 FVII HoFH KSP MTP SAA angiopoietin-like 3 ANGPTL3 TTR TMPRSS6 ALAS1 LNA MIR FXI PLK1 Oligonucleotides Gcgr polo like kinase 1 2′-O-methoxyethyl transthyretin HCC short interfering RNA siRNA Antisense Locked Nucleic Acid Liver disease RISC serum amyloid A Factor VII Factor XI Vascular endothelial growth factor Vascular Endothelial Growth Factor (VEGF)low density lipoprotein LDL RNA Induced Silencing Complex UTR یا untranslated regions untranslated region MicroRNA MiRNA Hepatitis C virus HCV Homozygous familial hypercholesterolemia MOE Kinesin spindle protein microsomal triglyceride transfer protein Proprotein convertase subtilisin/kexin type 9 Hepatocellular carcinoma Glucagon receptor

Related Topics

Health Sciences Medicine and Dentistry Gastroenterology

Liver as a target for oligonucleotide therapeutics

Authors

Alfica Sehgal, Akshay Vaishnaw, Kevin Fitzgerald,